Chronic Myeloid Leukemia


FDA Grants Accelerated Approval to Bosulif for Treatment of Newly-Diagnosed Chronic Myelogenous Leukemia (01-14-2018)

CancerConnect News: On December 19, 2017, the Food and Drug Administration granted accelerated approval to bosutinib Bosulif (bosutinib) for treatment of patients with newly-diagnosed chronic phase (CP) Philadelphia chromosome positive (Ph+) chronic myelogenous... Continue Reading

CML Patients Treated with Gleevec Have Normal Life Expectancy (03-31-2011)

People with chronic myeloid leukemia (CML) that is in complete remission after two years of treatment with Gleevec® (imatinib) have survival rates that are similar to those of the general population. These results were published in the Journal of the... Continue Reading

Cancer’s Glamour Girl (03-20-2009)

Down-to-earth and down-to-business when it comes to cancer advocacy, Erin Zammett Ruddy discusses her very public journey with chronic myeloid leukemia and why she continues to share her story. by Diana Price Erin Zammett Ruddy always wanted to be famous—at... Continue Reading

LYN Kinase Affects Sensitivity to Gleevec® in Chronic Myeloid Leukemia (07-1-2008)

LYN Kinase Affects Sensitivity to Gleevec® in Chronic Myeloid Leukemia A protein structure known as the LYN kinase appears to play an important role in the effectiveness of Gleevec® (imatinib mesylate) in chronic myeloid leukemia (CML) cancer cells.... Continue Reading